Boundless Bio Inc.. (BOLD) NASDAQ

$14.25 (1.75) (-10.94%)

Market Cap: -

As of 03/28/24 04:00 PM EDT. Market closed.

(BOLD)

Boundless Bio Inc.. (BOLD)
NASDAQ

$14.25
(1.75) (-10.94%)

Market Cap: -

As of 03/28/24 04:00 PM EDT. Market closed.

Add to Portfolio

Audentes Therapeutics, Inc. is a biotechnology company, which engages on development and commercialization of gene therapy products for patients with serious and rare diseases caused by single gene defects. Its products include AT001 for the treatment of X-Linked Myotubular Myopathy, AT002 for the treatment of Pompe disease, and AT003 for the treatment of Catecholaminergic Polymorphic Ventricular ... read more

Audentes Therapeutics, Inc. is a biotechnology company, which engages on development and commercialization of gene therapy products for patients with serious and rare diseases caused by single gene defects. Its products include AT001 for the treatment of X-Linked Myotubular Myopathy, AT002 for the treatment of Pompe disease, and AT003 for the treatment of Catecholaminergic Polymorphic Ventricular Tachycardia. The company was founded by Matthew R. Patterson and Thomas J. Schuetz on November 13, 2012 and is headquartered in San Francisco, CA. read less

COMPANY PROFILE
Sector
Health Technology
Industry
Biotechnology
CEO Compensation (Base)
$542,000
CEO Compensation (Total)
$780,480
URL
Address
600 California Street, CA, San Francisco, 94108.
Sector
Health Technology
Industry
Biotechnology
CEO
Natalie C. Holles
CEO Compensation (Base)
$542,000
CEO Compensation (Total)
$780,480
Address
600 California Street, CA, San Francisco, 94108.
PRICE CHART FOR BOUNDLESS BIO INC.
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$14.44
Previous Close
$16
Days Range
- - -
52 week range
- - -
Volume
1,754,212
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
0
Open
$14.44
Previous Close
$16
Days Range
- - -
52 week range
- - -
Volume
1,754,212
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
0
FINANCIAL STATEMENTS FOR BOUNDLESS BIO INC.
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR BOUNDLESS BIO INC.
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Soloway Thomas PExecutive Vice President, CFOJan 15, 2020 Option Exercise$60.00183,38411,003,0400Jan 15, 2020, 01:38 PM
Schuetz Thomas J.DirectorJan 15, 2020 Option Exercise$60.0089,6955,381,7000Jan 15, 2020, 01:36 PM
Patterson Matthew RChief Executive OfficerJan 15, 2020 Option Exercise$60.00171,81410,308,8400Jan 15, 2020, 01:35 PM
Patterson Matthew RChief Executive OfficerJan 15, 2020 Option Exercise$60.00261,45815,687,4800Jan 15, 2020, 01:35 PM
Mosbrooker EricSVP, Chief Commercial OfficerJan 15, 2020 Option Exercise$60.0026,9191,615,1400Jan 15, 2020, 01:34 PM
Meltz Mark ASVP, General CounselJan 15, 2020 Option Exercise$60.0032,7051,962,3000Jan 15, 2020, 01:32 PM
LANGE LOUIS GDirectorJan 15, 2020 Option Exercise$60.003,555213,3000Jan 15, 2020, 01:31 PM
LANGE LOUIS GDirectorJan 15, 2020 Option Exercise$60.0032,3431,940,5800Jan 15, 2020, 01:31 PM
LANGE LOUIS GDirectorJan 15, 2020 Option Exercise$60.0013,678820,6800Jan 15, 2020, 01:31 PM
LANGE LOUIS GDirectorJan 15, 2020 Option Exercise$60.00265,79915,947,9400Jan 15, 2020, 01:31 PM
Holles Natalie C.President and COOJan 15, 2020 Option Exercise$60.00104,4396,266,3400Jan 15, 2020, 01:29 PM
Goldberg Mark AlanDirectorJan 15, 2020 Option Exercise$60.001,50090,0000Jan 15, 2020, 01:27 PM
Conner Edward R.SVP, Chief Medical OfficerJan 15, 2020 Option Exercise$60.0024,5841,475,0400Jan 15, 2020, 01:26 PM
Soloway Thomas PExecutive Vice President, CFOJan 08, 2020 Option Exercise$3.28150,888494,897183,384Jan 10, 2020, 06:19 PM
Patterson Matthew RChief Executive OfficerJan 08, 2020 Option Exercise$3.10162,538503,567261,458Jan 10, 2020, 06:18 PM
LANGE LOUIS GDirectorDec 23, 2019 Sale$59.601,00059,59613,678Dec 27, 2019, 04:10 PM
LANGE LOUIS GDirectorDec 23, 2019 Sale$59.6010,000595,993265,799Dec 27, 2019, 04:10 PM
Soloway Thomas PExecutive Vice President, CFODec 12, 2019 Option Exercise$59.3730,1391,789,35232,496Dec 16, 2019, 06:05 PM
Soloway Thomas PExecutive Vice President, CFODec 12, 2019 Option Exercise$2.7641,321114,24853,954Dec 16, 2019, 06:05 PM
Mosbrooker EricSVP, Chief Commercial OfficerDec 12, 2019 Option Exercise$59.374,881289,78526,919Dec 16, 2019, 06:04 PM
Meltz Mark ASVP, General CounselDec 12, 2019 Option Exercise$59.374,628274,76432,705Dec 16, 2019, 06:04 PM
Holles Natalie C.President and COODec 12, 2019 Option Exercise$59.3797,6095,795,046104,439Dec 16, 2019, 06:03 PM
Holles Natalie C.President and COODec 12, 2019 Option Exercise$12.68147,3441,868,986193,367Dec 16, 2019, 06:03 PM
Conner Edward R.SVP, Chief Medical OfficerDec 12, 2019 Option Exercise$59.375,416321,54824,584Dec 16, 2019, 06:02 PM
Soloway Thomas PExecutive Vice President, CFODec 05, 2019 Option Exercise$59.2150529,90121,314Dec 09, 2019, 05:17 PM
Patterson Matthew RChief Executive OfficerDec 05, 2019 Option Exercise$59.211,974116,881111,420Dec 09, 2019, 05:16 PM
Holles Natalie C.President and COODec 05, 2019 Option Exercise$59.2150529,90154,704Dec 09, 2019, 05:15 PM
Patterson Matthew RChief Executive OfficerNov 08, 2019 Option Exercise$9.5014,426137,047127,820Nov 12, 2019, 05:32 PM
Patterson Matthew RChief Executive OfficerNov 08, 2019 Sale$30.0014,426432,780113,394Nov 12, 2019, 05:32 PM
LANGE LOUIS GDirectorSep 23, 2019 Sale$32.181,00032,18214,678Sep 25, 2019, 06:11 PM
LANGE LOUIS GDirectorSep 23, 2019 Sale$32.1610,000321,616276,044Sep 25, 2019, 06:11 PM
Soloway Thomas PExecutive Vice President, CFOSep 05, 2019 Option Exercise$31.0250515,66521,819Sep 09, 2019, 04:06 PM
Patterson Matthew RChief Executive OfficerSep 05, 2019 Option Exercise$31.021,97461,233113,394Sep 09, 2019, 04:05 PM
Holles Natalie C.President and COOSep 05, 2019 Option Exercise$31.0250515,66555,209Sep 09, 2019, 04:04 PM
Patterson Matthew RChief Executive OfficerAug 12, 2019 Option Exercise$9.5020,000190,000135,368Aug 14, 2019, 07:03 PM
Patterson Matthew RChief Executive OfficerAug 12, 2019 Sale$34.0420,000680,835116,368Aug 14, 2019, 07:03 PM
LANGE LOUIS GDirectorJun 24, 2019 Sale$38.201,00038,20115,878Jun 26, 2019, 04:07 PM
LANGE LOUIS GDirectorJun 24, 2019 Sale$37.7720,000755,413290,001Jun 26, 2019, 04:07 PM
PRASAD SUYASHSenior VP & Chief Med OfficerJun 05, 2019 Option Exercise$37.3175728,24417,479Jun 07, 2019, 04:42 PM
Patterson Matthew RChief Executive OfficerJun 05, 2019 Option Exercise$37.313,332124,317115,368Jun 07, 2019, 04:41 PM
Holles Natalie C.President and COOJun 05, 2019 Option Exercise$37.311,00937,64655,714Jun 07, 2019, 04:41 PM
Soloway Thomas PExecutive Vice President, CFOJun 05, 2019 Option Exercise$37.311,00937,64622,324Jun 07, 2019, 04:40 PM
PRASAD SUYASHSenior VP & Chief Med OfficerMay 13, 2019 Option Exercise$0.7910,0007,90028,236May 15, 2019, 04:42 PM
PRASAD SUYASHSenior VP & Chief Med OfficerMay 13, 2019 Sale$36.9810,000369,79818,290May 15, 2019, 04:42 PM
LANGE LOUIS GDirectorMar 25, 2019 Sale$36.001,00036,00416,678Mar 27, 2019, 05:03 PM
LANGE LOUIS GDirectorMar 25, 2019 Sale$36.0020,000720,015306,099Mar 27, 2019, 05:03 PM
LANGE LOUIS GDirectorMar 25, 2019 Sale$35.9455820,0550Mar 27, 2019, 05:03 PM
PRASAD SUYASHSenior VP & Chief Med OfficerFeb 25, 2019 Option Exercise$0.7910,0007,90028,236Feb 27, 2019, 04:32 PM
PRASAD SUYASHSenior VP & Chief Med OfficerFeb 25, 2019 Sale$30.0610,000300,55318,236Feb 27, 2019, 04:32 PM
Patterson Matthew RChief Executive OfficerFeb 25, 2019 Option Exercise$1.0521,00022,020135,700Feb 27, 2019, 04:31 PM
Patterson Matthew RChief Executive OfficerFeb 25, 2019 Sale$30.0021,000630,000118,700Feb 27, 2019, 04:31 PM
Holles Natalie C.President and COOJan 24, 2019 Option Exercise$2.768,30022,94933,390Jan 25, 2019, 07:28 PM
LANGE LOUIS GDirectorDec 24, 2018 Sale$18.5010,000184,95132,343Dec 27, 2018, 05:43 PM
LANGE LOUIS GDirectorDec 24, 2018 Sale$18.711,00018,713558Dec 27, 2018, 05:43 PM
LANGE LOUIS GDirectorDec 24, 2018 Sale$18.701,00018,70117,678Dec 27, 2018, 05:43 PM
LANGE LOUIS GDirectorDec 24, 2018 Sale$18.6720,000373,434325,799Dec 27, 2018, 05:43 PM
Patterson Matthew RChief Executive OfficerDec 06, 2018 Option Exercise$0.7840,00031,20055,000Dec 10, 2018, 04:39 PM
NEWMAN MARYSVP, Regulatory AffairsNov 15, 2018 Option Exercise$19.6466012,959660Nov 16, 2018, 06:41 PM
PRASAD SUYASHSenior VP & Chief Med OfficerNov 15, 2018 Option Exercise$19.6473614,451736Nov 16, 2018, 06:37 PM
LANGE LOUIS GDirectorNov 15, 2018 Sale$22.494,00089,9603,555Nov 16, 2018, 06:34 PM
LANGE LOUIS GDirectorNov 15, 2018 Sale$22.4920,000449,800345,799Nov 16, 2018, 06:34 PM
PRASAD SUYASHSenior VP & Chief Med OfficerOct 01, 2018 Option Exercise$0.7910,0007,9004,699Oct 02, 2018, 07:05 PM
PRASAD SUYASHSenior VP & Chief Med OfficerOct 01, 2018 Sale$36.8810,000368,7880Oct 02, 2018, 07:05 PM
Patterson Matthew RChief Executive OfficerOct 01, 2018 Option Exercise$0.7821,00016,38023,078Oct 02, 2018, 07:04 PM
Patterson Matthew RChief Executive OfficerOct 01, 2018 Sale$38.1621,000801,37215,000Oct 02, 2018, 07:04 PM
GRAY JOHN T.SVP, Chief Scientific OfficerSep 28, 2018 Option Exercise$1.05879187Oct 02, 2018, 07:03 PM
GRAY JOHN T.SVP, Chief Scientific OfficerSep 28, 2018 Sale$40.00873,4800Oct 02, 2018, 07:03 PM
LANGE LOUIS GDirectorSep 24, 2018 Sale$37.251,00037,2507,555Sep 26, 2018, 07:00 PM
LANGE LOUIS GDirectorSep 24, 2018 Sale$37.3520,000747,061365,999Sep 26, 2018, 07:00 PM
LANGE LOUIS GDirectorSep 24, 2018 Sale$37.4510,000374,53642,343Sep 26, 2018, 07:00 PM
LANGE LOUIS GDirectorSep 24, 2018 Sale$37.271,00037,2671,558Sep 26, 2018, 07:00 PM
LANGE LOUIS GDirectorSep 24, 2018 Sale$37.271,00037,26618,678Sep 26, 2018, 07:00 PM
Patterson Matthew RChief Executive OfficerSep 24, 2018 Option Exercise$0.7815,00011,70015,000Sep 24, 2018, 06:12 PM
Patterson Matthew RChief Executive OfficerSep 18, 2018 Option Exercise$2.1912,95228,36512,952Sep 20, 2018, 07:01 PM
Patterson Matthew RChief Executive OfficerSep 18, 2018 Sale$40.0012,952518,0800Sep 20, 2018, 07:01 PM
PRASAD SUYASHSenior VP & Chief Med OfficerJul 02, 2018 Option Exercise$0.7910,0007,9005,011Jul 05, 2018, 06:35 PM
PRASAD SUYASHSenior VP & Chief Med OfficerJul 02, 2018 Sale$38.4110,000384,0670Jul 05, 2018, 06:35 PM
Patterson Matthew RChief Executive OfficerJul 05, 2018 Option Exercise$0.7823,14718,05523,147Jul 05, 2018, 06:34 PM
Patterson Matthew RChief Executive OfficerJul 03, 2018 Option Exercise$0.7826,90120,98326,901Jul 05, 2018, 06:34 PM
Patterson Matthew RChief Executive OfficerJul 02, 2018 Option Exercise$0.7821,00016,38019,599Jul 05, 2018, 06:34 PM
Patterson Matthew RChief Executive OfficerJul 05, 2018 Sale$40.0423,147926,8520Jul 05, 2018, 06:34 PM
Patterson Matthew RChief Executive OfficerJul 03, 2018 Sale$40.0526,9011,077,4600Jul 05, 2018, 06:34 PM
Patterson Matthew RChief Executive OfficerJul 02, 2018 Sale$38.3621,000805,5240Jul 05, 2018, 06:34 PM
NEWMAN MARYSVP, Regulatory AffairsJun 25, 2018 Option Exercise$2.198,54518,6738,245Jun 27, 2018, 06:52 PM
NEWMAN MARYSVP, Regulatory AffairsJun 25, 2018 Sale$40.798,545348,5810Jun 27, 2018, 06:52 PM
LANGE LOUIS GDirectorJun 25, 2018 Sale$40.8710,000408,70452,553Jun 27, 2018, 06:51 PM
LANGE LOUIS GDirectorJun 25, 2018 Sale$40.811,00040,8092,658Jun 27, 2018, 06:51 PM
LANGE LOUIS GDirectorJun 25, 2018 Sale$40.861,00040,85819,778Jun 27, 2018, 06:51 PM
LANGE LOUIS GDirectorJun 25, 2018 Sale$40.781,00040,7838,555Jun 27, 2018, 06:51 PM
LANGE LOUIS GDirectorJun 25, 2018 Sale$40.4220,000808,344386,939Jun 27, 2018, 06:51 PM
Nagler DavidSVP, HR & Corp. AffairsJun 20, 2018 Option Exercise$2.195,00010,9264,700Jun 22, 2018, 07:11 PM
Nagler DavidSVP, HR & Corp. AffairsJun 20, 2018 Sale$45.295,000226,4610Jun 22, 2018, 07:11 PM
Holles Natalie C.President and COOJun 01, 2018 Option Exercise$2.765,09014,07325,090Jun 04, 2018, 04:48 PM
Patterson Matthew RPresident & CEOMay 21, 2018 Option Exercise$0.7820,30015,83413,600May 23, 2018, 06:13 PM
Patterson Matthew RPresident & CEOMay 21, 2018 Sale$38.1520,300774,4980May 23, 2018, 06:13 PM
Patterson Matthew RPresident & CEOApr 02, 2018 Option Exercise$0.78700546700Apr 04, 2018, 09:01 PM
Patterson Matthew RPresident & CEOApr 02, 2018 Sale$30.0170021,0090Apr 04, 2018, 09:01 PM
NEWMAN MARYSVP, Regulatory AffairsMar 15, 2018 Option Exercise$2.1910,00021,9005,524Apr 02, 2018, 09:06 PM
NEWMAN MARYSVP, Regulatory AffairsMar 15, 2018 Sale$30.3610,000303,6270Apr 02, 2018, 09:06 PM
PRASAD SUYASHSenior VP & Chief Med OfficerMar 29, 2018 Option Exercise$0.797,8006,1627,800Mar 29, 2018, 08:23 PM
PRASAD SUYASHSenior VP & Chief Med OfficerMar 29, 2017 Sale$30.027,800234,1950Mar 29, 2018, 08:23 PM
PRASAD SUYASHSenior VP & Chief Med OfficerMar 27, 2018 Option Exercise$0.79300237300Mar 28, 2018, 09:12 PM
PRASAD SUYASHSenior VP & Chief Med OfficerMar 26, 2018 Option Exercise$0.791,9001,5011,900Mar 28, 2018, 09:12 PM
PRASAD SUYASHSenior VP & Chief Med OfficerMar 26, 2018 Sale$30.001,90057,0000Mar 28, 2018, 09:12 PM
PRASAD SUYASHSenior VP & Chief Med OfficerMar 27, 2017 Sale$30.003009,0000Mar 28, 2018, 09:12 PM
LANGE LOUIS GDirectorMar 26, 2018 Sale$28.5925,000714,81868,943Mar 28, 2018, 09:11 PM
LANGE LOUIS GDirectorMar 26, 2018 Sale$28.921,00028,9244,041Mar 28, 2018, 09:11 PM
LANGE LOUIS GDirectorMar 26, 2018 Sale$28.861,00028,85721,078Mar 28, 2018, 09:11 PM
LANGE LOUIS GDirectorMar 26, 2018 Sale$28.871,00028,87410,055Mar 28, 2018, 09:11 PM
LANGE LOUIS GDirectorMar 26, 2018 Sale$29.2720,000585,464414,231Mar 28, 2018, 09:11 PM
ORBIMED ADVISORS LLC10% OwnerMar 08, 2018 Sale$34.0658,4281,990,0583,638,000Mar 12, 2018, 06:16 PM
ORBIMED ADVISORS LLC10% OwnerMar 12, 2018 Sale$34.9918,003629,8593,556,934Mar 12, 2018, 06:16 PM
ORBIMED ADVISORS LLC10% OwnerMar 09, 2018 Sale$35.6380,0002,850,0103,616,700Mar 12, 2018, 06:16 PM
ORBIMED ADVISORS LLC10% OwnerMar 06, 2018 Sale$33.0311,372375,6173,696,428Mar 06, 2018, 05:53 PM
ORBIMED ADVISORS LLC10% OwnerMar 05, 2018 Sale$36.062007,2123,707,800Mar 06, 2018, 05:53 PM
ORBIMED ADVISORS LLC10% OwnerMar 02, 2018 Sale$35.17421,63814,827,7883,743,558Mar 06, 2018, 05:53 PM
LANGE LOUIS GDirectorDec 22, 2017 Sale$30.901,00030,90210,555Dec 26, 2017, 07:38 PM
LANGE LOUIS GDirectorDec 22, 2017 Sale$30.8815,000463,160425,799Dec 26, 2017, 07:38 PM
LANGE LOUIS GDirectorDec 22, 2017 Sale$30.871,00030,8734,558Dec 26, 2017, 07:38 PM
LANGE LOUIS GDirectorDec 22, 2017 Sale$30.861,00030,85821,678Dec 26, 2017, 07:38 PM
PRASAD SUYASHSenior VP & Chief Med OfficerDec 01, 2017 Option Exercise$0.798,0006,3206,770Dec 05, 2017, 04:00 PM
PRASAD SUYASHSenior VP & Chief Med OfficerDec 01, 2017 Sale$28.538,000228,2640Dec 05, 2017, 04:00 PM
NEWMAN MARYSVP, Regulatory AffairsNov 16, 2017 Option Exercise$2.1910,00021,9005,740Nov 17, 2017, 05:06 PM
NEWMAN MARYSVP, Regulatory AffairsNov 16, 2017 Sale$26.8410,000268,3750Nov 17, 2017, 05:06 PM
Patterson Matthew RPresident & CEOOct 02, 2017 Option Exercise$0.7810,0007,80010,000Oct 04, 2017, 08:25 PM
Patterson Matthew RPresident & CEOOct 02, 2017 Sale$27.9215,000418,853171,814Oct 04, 2017, 08:25 PM
Patterson Matthew RPresident & CEOOct 02, 2017 Sale$27.9210,000279,2170Oct 04, 2017, 08:25 PM
ORBIMED ADVISORS LLC10% OwnerSep 29, 2017 Sale$28.25672,00018,984,0004,129,638Sep 29, 2017, 06:06 PM
Nagler DavidSVP, HR & Corp. AffairsSep 27, 2017 Option Exercise$2.193,7508,1943,750Sep 29, 2017, 05:48 PM
Nagler DavidSVP, HR & Corp. AffairsSep 27, 2017 Sale$30.003,750112,5000Sep 29, 2017, 05:48 PM
LANGE LOUIS GDirectorSep 29, 2017 Sale$28.252,00056,50322,878Sep 29, 2017, 05:47 PM
LANGE LOUIS GDirectorSep 29, 2017 Sale$28.292,00056,58811,855Sep 29, 2017, 05:47 PM
LANGE LOUIS GDirectorSep 29, 2017 Sale$28.465,000142,315441,555Sep 29, 2017, 05:47 PM
LANGE LOUIS GDirectorSep 29, 2017 Sale$28.252,00056,4975,758Sep 29, 2017, 05:47 PM
LANGE LOUIS GDirectorSep 25, 2017 Sale$28.3115,000424,672453,393Sep 26, 2017, 05:44 PM
LANGE LOUIS GDirectorSep 25, 2017 Sale$28.361,00028,3577,917Sep 26, 2017, 05:44 PM
LANGE LOUIS GDirectorSep 25, 2017 Sale$28.351,00028,34725,042Sep 26, 2017, 05:44 PM
LANGE LOUIS GDirectorSep 25, 2017 Sale$28.351,00028,35113,955Sep 26, 2017, 05:44 PM
Patterson Matthew RPresident & CEOSep 18, 2017 Option Exercise$0.788,4586,5978,458Sep 19, 2017, 06:00 PM
Patterson Matthew RPresident & CEOSep 15, 2017 Option Exercise$0.781,5421,2031,542Sep 19, 2017, 06:00 PM
Patterson Matthew RPresident & CEOSep 18, 2017 Sale$25.078,458212,0100Sep 19, 2017, 06:00 PM
Patterson Matthew RPresident & CEOSep 15, 2017 Sale$25.001,54238,5510Sep 19, 2017, 06:00 PM
Nagler DavidSVP, HR & Corp. AffairsSep 15, 2017 Option Exercise$2.193,7508,1943,750Sep 19, 2017, 05:59 PM
Nagler DavidSVP, HR & Corp. AffairsSep 15, 2017 Sale$25.003,75093,7500Sep 19, 2017, 05:59 PM
ORBIMED ADVISORS LLC10% OwnerSep 07, 2017 Sale$22.355,000111,7504,801,638Sep 11, 2017, 02:16 PM
ORBIMED ADVISORS LLC10% OwnerSep 07, 2017 Option Exercise$15.035,00075,1504,806,638Sep 11, 2017, 02:16 PM
PRASAD SUYASHSenior VP & Chief Med OfficerSep 01, 2017 Option Exercise$0.798,0006,3208,000Sep 01, 2017, 05:55 PM
PRASAD SUYASHSenior VP & Chief Med OfficerSep 01, 2017 Sale$21.448,000171,4810Sep 01, 2017, 05:55 PM
NEWMAN MARYSVP, Regulatory AffairsAug 24, 2017 Option Exercise$2.1910,00021,90010,000Aug 25, 2017, 04:17 PM
NEWMAN MARYSVP, Regulatory AffairsAug 24, 2017 Sale$20.0010,000200,0000Aug 25, 2017, 04:17 PM
Patterson Matthew RPresident & CEOJul 13, 2017 Sale$20.0012,150243,052186,814Jul 14, 2017, 08:01 PM
Patterson Matthew RPresident & CEOJul 12, 2017 Sale$20.002,85057,007198,964Jul 14, 2017, 08:01 PM
LANGE LOUIS GDirectorJun 26, 2017 Sale$19.7815,000296,682470,799Jun 28, 2017, 04:42 PM
Holles Natalie C.Senior Vice President, COOMay 31, 2017 Option Exercise$2.7620,00055,20020,000Jun 01, 2017, 04:31 PM
5AM Partners III, LLCformer 10% ownerApr 24, 2017 Buy$14.50168,0822,437,1892,500,113Apr 26, 2017, 08:17 PM
5AM Partners III, LLCformer 10% ownerApr 24, 2017 Buy$14.504,33162,80064,431Apr 26, 2017, 08:17 PM
Woiwode ThomasDirectorJul 25, 2016 Buy$15.002193,28511,308Jul 25, 2016, 05:09 PM
Woiwode ThomasDirectorJul 25, 2016 Buy$15.0034,781521,7151,795,524Jul 25, 2016, 05:09 PM
Versant Ventures IV, LLC10% OwnerJul 25, 2016 Buy$15.002193,28511,308Jul 25, 2016, 05:08 PM
Versant Ventures IV, LLC10% OwnerJul 25, 2016 Buy$15.0034,781521,7151,795,524Jul 25, 2016, 05:08 PM
SILVERSTEIN JONATHANDirectorJul 25, 2016 Buy$15.0033,334500,0104,801,638Jul 25, 2016, 05:08 PM
ORBIMED ADVISORS LLCDirectorJul 25, 2016 Buy$15.0033,334500,0104,801,638Jul 25, 2016, 05:07 PM
5AM Partners III, LLC10% OwnerJul 25, 2016 Buy$15.0068,2411,023,6152,332,031Jul 25, 2016, 05:06 PM
5AM Partners III, LLC10% OwnerJul 25, 2016 Buy$15.001,75926,38560,100Jul 25, 2016, 05:06 PM
Flynn James E10% OwnerJul 25, 2016 Buy$15.00146,5962,198,940514,424Jul 25, 2016, 12:19 PM
Flynn James E10% OwnerJul 25, 2016 Buy$15.00253,4043,801,060889,230Jul 25, 2016, 12:19 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Soloway Thomas PExecutive Vice President, CFO01/15/202011,003,040
Schuetz Thomas J.Director01/15/20205,381,700
Patterson Matthew RChief Executive Officer01/15/202010,308,840
Patterson Matthew RChief Executive Officer01/15/202015,687,480
Mosbrooker EricSVP, Chief Commercial Officer01/15/20201,615,140
Meltz Mark ASVP, General Counsel01/15/20201,962,300
LANGE LOUIS GDirector01/15/2020213,300
LANGE LOUIS GDirector01/15/20201,940,580
LANGE LOUIS GDirector01/15/2020820,680
LANGE LOUIS GDirector01/15/202015,947,940
Holles Natalie C.President and COO01/15/20206,266,340
Goldberg Mark AlanDirector01/15/202090,000
Conner Edward R.SVP, Chief Medical Officer01/15/20201,475,040
Soloway Thomas PExecutive Vice President, CFO01/08/2020494,897
Patterson Matthew RChief Executive Officer01/08/2020503,567
LANGE LOUIS GDirector12/23/201959,596
LANGE LOUIS GDirector12/23/2019595,993
Soloway Thomas PExecutive Vice President, CFO12/12/20191,789,352
Soloway Thomas PExecutive Vice President, CFO12/12/2019114,248
Mosbrooker EricSVP, Chief Commercial Officer12/12/2019289,785
Meltz Mark ASVP, General Counsel12/12/2019274,764
Holles Natalie C.President and COO12/12/20195,795,046
Holles Natalie C.President and COO12/12/20191,868,986
Conner Edward R.SVP, Chief Medical Officer12/12/2019321,548
Soloway Thomas PExecutive Vice President, CFO12/05/201929,901
Patterson Matthew RChief Executive Officer12/05/2019116,881
Holles Natalie C.President and COO12/05/201929,901
Patterson Matthew RChief Executive Officer11/08/2019137,047
Patterson Matthew RChief Executive Officer11/08/2019432,780
LANGE LOUIS GDirector09/23/201932,182
LANGE LOUIS GDirector09/23/2019321,616
Soloway Thomas PExecutive Vice President, CFO09/05/201915,665
Patterson Matthew RChief Executive Officer09/05/201961,233
Holles Natalie C.President and COO09/05/201915,665
Patterson Matthew RChief Executive Officer08/12/2019190,000
Patterson Matthew RChief Executive Officer08/12/2019680,835
LANGE LOUIS GDirector06/24/201938,201
LANGE LOUIS GDirector06/24/2019755,413
PRASAD SUYASHSenior VP & Chief Med Officer06/05/201928,244
Patterson Matthew RChief Executive Officer06/05/2019124,317
Holles Natalie C.President and COO06/05/201937,646
Soloway Thomas PExecutive Vice President, CFO06/05/201937,646
PRASAD SUYASHSenior VP & Chief Med Officer05/13/20197,900
PRASAD SUYASHSenior VP & Chief Med Officer05/13/2019369,798
LANGE LOUIS GDirector03/25/201936,004
LANGE LOUIS GDirector03/25/2019720,015
LANGE LOUIS GDirector03/25/201920,055
PRASAD SUYASHSenior VP & Chief Med Officer02/25/20197,900
PRASAD SUYASHSenior VP & Chief Med Officer02/25/2019300,553
Patterson Matthew RChief Executive Officer02/25/201922,020
Patterson Matthew RChief Executive Officer02/25/2019630,000
Holles Natalie C.President and COO01/24/201922,949
LANGE LOUIS GDirector12/24/2018184,951
LANGE LOUIS GDirector12/24/201818,713
LANGE LOUIS GDirector12/24/201818,701
LANGE LOUIS GDirector12/24/2018373,434
Patterson Matthew RChief Executive Officer12/06/201831,200
NEWMAN MARYSVP, Regulatory Affairs11/15/201812,959
PRASAD SUYASHSenior VP & Chief Med Officer11/15/201814,451
LANGE LOUIS GDirector11/15/201889,960
LANGE LOUIS GDirector11/15/2018449,800
PRASAD SUYASHSenior VP & Chief Med Officer10/01/20187,900
PRASAD SUYASHSenior VP & Chief Med Officer10/01/2018368,788
Patterson Matthew RChief Executive Officer10/01/201816,380
Patterson Matthew RChief Executive Officer10/01/2018801,372
GRAY JOHN T.SVP, Chief Scientific Officer09/28/201891
GRAY JOHN T.SVP, Chief Scientific Officer09/28/20183,480
LANGE LOUIS GDirector09/24/201837,250
LANGE LOUIS GDirector09/24/2018747,061
LANGE LOUIS GDirector09/24/2018374,536
LANGE LOUIS GDirector09/24/201837,267
LANGE LOUIS GDirector09/24/201837,266
Patterson Matthew RChief Executive Officer09/24/201811,700
Patterson Matthew RChief Executive Officer09/18/201828,365
Patterson Matthew RChief Executive Officer09/18/2018518,080
PRASAD SUYASHSenior VP & Chief Med Officer07/02/20187,900
PRASAD SUYASHSenior VP & Chief Med Officer07/02/2018384,067
Patterson Matthew RChief Executive Officer07/05/201818,055
Patterson Matthew RChief Executive Officer07/03/201820,983
Patterson Matthew RChief Executive Officer07/02/201816,380
Patterson Matthew RChief Executive Officer07/05/2018926,852
Patterson Matthew RChief Executive Officer07/03/20181,077,460
Patterson Matthew RChief Executive Officer07/02/2018805,524
NEWMAN MARYSVP, Regulatory Affairs06/25/201818,673
NEWMAN MARYSVP, Regulatory Affairs06/25/2018348,581
LANGE LOUIS GDirector06/25/2018408,704
LANGE LOUIS GDirector06/25/201840,809
LANGE LOUIS GDirector06/25/201840,858
LANGE LOUIS GDirector06/25/201840,783
LANGE LOUIS GDirector06/25/2018808,344
Nagler DavidSVP, HR & Corp. Affairs06/20/201810,926
Nagler DavidSVP, HR & Corp. Affairs06/20/2018226,461
Holles Natalie C.President and COO06/01/201814,073
Patterson Matthew RPresident & CEO05/21/201815,834
Patterson Matthew RPresident & CEO05/21/2018774,498
Patterson Matthew RPresident & CEO04/02/2018546
Patterson Matthew RPresident & CEO04/02/201821,009
NEWMAN MARYSVP, Regulatory Affairs03/15/201821,900
NEWMAN MARYSVP, Regulatory Affairs03/15/2018303,627
PRASAD SUYASHSenior VP & Chief Med Officer03/29/20186,162
PRASAD SUYASHSenior VP & Chief Med Officer03/29/2017234,195
PRASAD SUYASHSenior VP & Chief Med Officer03/27/2018237
PRASAD SUYASHSenior VP & Chief Med Officer03/26/20181,501
PRASAD SUYASHSenior VP & Chief Med Officer03/26/201857,000
PRASAD SUYASHSenior VP & Chief Med Officer03/27/20179,000
LANGE LOUIS GDirector03/26/2018714,818
LANGE LOUIS GDirector03/26/201828,924
LANGE LOUIS GDirector03/26/201828,857
LANGE LOUIS GDirector03/26/201828,874
LANGE LOUIS GDirector03/26/2018585,464
ORBIMED ADVISORS LLC10% Owner03/08/20181,990,058
ORBIMED ADVISORS LLC10% Owner03/12/2018629,859
ORBIMED ADVISORS LLC10% Owner03/09/20182,850,010
ORBIMED ADVISORS LLC10% Owner03/06/2018375,617
ORBIMED ADVISORS LLC10% Owner03/05/20187,212
ORBIMED ADVISORS LLC10% Owner03/02/201814,827,788
LANGE LOUIS GDirector12/22/201730,902
LANGE LOUIS GDirector12/22/2017463,160
LANGE LOUIS GDirector12/22/201730,873
LANGE LOUIS GDirector12/22/201730,858
PRASAD SUYASHSenior VP & Chief Med Officer12/01/20176,320
PRASAD SUYASHSenior VP & Chief Med Officer12/01/2017228,264
NEWMAN MARYSVP, Regulatory Affairs11/16/201721,900
NEWMAN MARYSVP, Regulatory Affairs11/16/2017268,375
Patterson Matthew RPresident & CEO10/02/20177,800
Patterson Matthew RPresident & CEO10/02/2017418,853
Patterson Matthew RPresident & CEO10/02/2017279,217
ORBIMED ADVISORS LLC10% Owner09/29/201718,984,000
Nagler DavidSVP, HR & Corp. Affairs09/27/20178,194
Nagler DavidSVP, HR & Corp. Affairs09/27/2017112,500
LANGE LOUIS GDirector09/29/201756,503
LANGE LOUIS GDirector09/29/201756,588
LANGE LOUIS GDirector09/29/2017142,315
LANGE LOUIS GDirector09/29/201756,497
LANGE LOUIS GDirector09/25/2017424,672
LANGE LOUIS GDirector09/25/201728,357
LANGE LOUIS GDirector09/25/201728,347
LANGE LOUIS GDirector09/25/201728,351
Patterson Matthew RPresident & CEO09/18/20176,597
Patterson Matthew RPresident & CEO09/15/20171,203
Patterson Matthew RPresident & CEO09/18/2017212,010
Patterson Matthew RPresident & CEO09/15/201738,551
Nagler DavidSVP, HR & Corp. Affairs09/15/20178,194
Nagler DavidSVP, HR & Corp. Affairs09/15/201793,750
ORBIMED ADVISORS LLC10% Owner09/07/2017111,750
ORBIMED ADVISORS LLC10% Owner09/07/201775,150
PRASAD SUYASHSenior VP & Chief Med Officer09/01/20176,320
PRASAD SUYASHSenior VP & Chief Med Officer09/01/2017171,481
NEWMAN MARYSVP, Regulatory Affairs08/24/201721,900
NEWMAN MARYSVP, Regulatory Affairs08/24/2017200,000
Patterson Matthew RPresident & CEO07/13/2017243,052
Patterson Matthew RPresident & CEO07/12/201757,007
LANGE LOUIS GDirector06/26/2017296,682
Holles Natalie C.Senior Vice President, COO05/31/201755,200
5AM Partners III, LLCformer 10% owner04/24/20172,437,189
5AM Partners III, LLCformer 10% owner04/24/201762,800
Woiwode ThomasDirector07/25/20163,285
Woiwode ThomasDirector07/25/2016521,715
Versant Ventures IV, LLC10% Owner07/25/20163,285
Versant Ventures IV, LLC10% Owner07/25/2016521,715
SILVERSTEIN JONATHANDirector07/25/2016500,010
ORBIMED ADVISORS LLCDirector07/25/2016500,010
5AM Partners III, LLC10% Owner07/25/20161,023,615
5AM Partners III, LLC10% Owner07/25/201626,385
Flynn James E10% Owner07/25/20162,198,940
Flynn James E10% Owner07/25/20163,801,060
Load More Insider Transactions
BUYBACK ANNOUNCEMENT(S) FOR BOUNDLESS BIO INC.
LOADING...